Frequently asked questions for health care practitioners and patients
I am a patient who is interested in getting on a trial with cabozantinib, how do I find out more information?
For additional information on participating in a clinical trial of cabozantinib, please speak with your health care provider and visit the ClinicalTrials.gov Web Site to find a clinical trial site in your area.
I am a health care practitioner who wants to put one of my patients on a cabozantinib trial, what steps do I need to take?
Please visit the ClinicalTrials.gov Web Site to find a clinical trial site in your area.
I am a health care practitioner and want to know how can I get access to a supply of cabozantinib for my patient?
Currently, Exelixis does not have an expanded access program for cabozantinib. Access to cabozantinib is only available to patients enrolled in a clinical trial. For information on cabozantinib clinical trials and to find clinical trial sites in your area, please visit the ClinicalTrials.gov Web Site.
How can I enroll a patient in the ongoing castration-resistant prostate cancer or ovarian cancer non-randomized extension cohorts?
Both the castration-resistant prostate cancer and ovarian cancer non-randomized extension trials of the RDT are currently accruing patients. To enroll patients in these trials, please visit the NCT00940225 Web Page on the ClinicalTrials.gov Web Site to find and contact a participating clinical trial site in your area.